Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats

The pharmacokinetic properties of ceftazidime, a third generation cephalosporin, were investigated in five cats after single intravenous (IV) and intramuscular (IM) administration at a dose rate of 30 mg/kg. Minimum inhibitory concentrations (MICs) of ceftazidime for some Gram-negative (Escherichia coli, n=11) and Gram-positive (Staphylococcus spp., n=10) strains isolated from clinical cases were determined. An efficacy predictor, measured as the time over which the active drug exceeds the bacteria minimum inhibitory concentration (T>MIC), was calculated. Serum ceftazidime disposition was best fitted by a bi-compartmental and a mono-compartmental open model with first-order elimination after IV and IM dosing, respectively. After IV administration, distribution was rapid (t(1/2(d)) 0.04+/-0.03 h), with an area under the ceftazidime serum concentration:time curve (AUC((0-infinity))) of 173.14+/-48.69 microg h/mL and a volume of distribution (V((d(ss)))) of 0.18+/-0.04 L/kg. Furthermore, elimination was rapid with a plasma clearance of 0.19+/-0.08 L/hkg and a t(1/2) of 0.77+/-0.06 h. Peak serum concentration (C(max)), T(max), AUC((0-infinity)) and bioavailability for the IM administration were 89.42+/-12.15 microg/mL, 0.48+/-0.49 h, 192.68+/-65.28 microg h/mL and 82.47+/-14.37%, respectively. Ceftazidime MIC for E. coli ranged from 0.0625 to 32 microg/mL and for Staphylococcus spp. from 1 to 64 microg/mL. T>MIC was in the range 35-52% (IV) and 48-72% (IM) of the recommended dosing interval (8-12h) for bacteria with a MIC(90)4 microg/mL.     

Dynamics of <Emphasis Type="Italic">Mycoplasma hyopneumoniae</Emphasis> seroconversion and infection in pigs in the three main production systems

In this study, we investigated the dynamics of Mycoplasma hyopneumoniae infections in 66 pig farms, with different production systems (one-, two-, and three-site systems), and considered different risk factors. Serological assay was used to detect serum antibodies against M. hyopneumoniae and real time polymerase chain reaction (RT–PCR) was performed to detect M. hyopneumoniae DNA in tracheobronchial swabs. Results demonstrated that M. hyopneumoniae infection status was predominantly influenced by the age of the animals and the type of production system. Infection rates were higher in older animals and the prevalence was higher in the one- and two-site systems than in the three-site systems. Dynamics of infection by RT-PCR showed that earlier M. hyopneumoniae infection on one-site farms occurs earlier, while on two- and three-site farms occurs later but spreads faster, suggesting that contact between animals of different age favors the transmission.     

The pharmacokinetics of a slow-release theophylline preparation in horses after intravenous and oral administration

The pharmacokinetics of a slow-release theophylline formulation was investigated following intravenous and oral administration at 10 mg/kg in horses. A tricompartmental model was selected to describe the intravenous plasma profile. The elimination half-life (t1/2) was 16.91 ± 0.93 h, the apparent volume of distribution (V _d) was 1.35 ± 0.18 L/kg and the body clearance (Cl_B) was 0.061 ± 0.009 L kg^–1 h. After oral administration the half-life of absorption was 1.24 ± 0.30 h, and the calculated bioavailability was above 100%. Thet1/2 after oral administration was 18.51 ± 1.75 h, only a little longer than that after intravenous administration. The slow release formulation did not exhibit any advantage in prolonging thet1/2 of theophylline in the horse.     

两种普鲁兰类酵母菌株Aureobasidium pullulans对三种核果类褐腐病菌Monilinia laxa,Monilinia fructicola和Monilinia fructigena的生物控制作用

本试验研究了从"Redhaven"桃果肉中分离得到的两种拮抗酵母菌株L1和L8对三种核果类褐腐病原菌(Monilinia laxa,Monilinia fructicola及Monilinia fructigena)的离体和活体拮抗效果。这两种拮抗菌株是经初步验证能够减轻桃和油桃的褐腐病症状后筛选出的,并最终通过分子生物学及形态学手段鉴定为Aureobasidium pullulans(出芽短梗霉菌)。通过活体接种三种褐腐病菌的试验研究发现,两种拮抗菌的高压灭菌悬液及无菌过滤液对果实褐腐病的发生均无抑制作用,而含有L1和L8菌株的菌悬液可完全抑制M.laxa和M.fructicola引起的褐腐病的发生,并使M.fructigena引起的褐腐病发病率分别降低70%和90%。在另一项试验中,将油桃用两种拮抗菌液处理后接种三种褐腐病菌,然后将其在0℃下贮藏21 d,再在20℃下放置7 d。结果表明,低温抑制了褐腐病的发生,处理和对照果实均无褐腐病的症状。但在20℃下放置7 d后,对照果实的褐腐病发病率均超过了45%,而LI和L8处理分别可以将接种M.fructigena病原菌果实褐腐病的发病率降低89.8%和91.2%,说明两种拮抗菌的处理可完全抑制接种M.laxa和M.fructicola引起的果实褐腐病的发生。两种拮抗酵母菌株的最佳抑菌浓度为108CFU.mL-1,L1在107CFU.mL-1浓度时也具有较好的抑菌效果。L8菌株在107CFU.mL-1浓度时对由M.fructigena和M.fructicola引起的果实褐腐病无抑制活性,处理与对照果实无差异。而对于接种了M.laxa的油桃果实,与对照相比,107CFU.mL-1浓度的L8菌株却可显著降低褐腐病的发病率。尽管在0℃和20℃下贮藏的油桃果实伤口处的L1和L8菌的数量增长较慢,但已经足够控制果实褐腐病的发生。综上所述,本项研究确定了可作为开发采后生物杀菌剂活性成分的两种A.pullulans拮抗菌株,并用于抑制引起核果类作物采后严重经济损失的三种Monilinia真菌。     

Current concepts on the use of antimicrobials in cats

This article reviews the general pharmacological properties of antimicrobial drugs used in feline medicine. It focuses on recent advances in pharmacokinetics, providing an update on indications, drug interactions and adverse reactions or toxicity in the cat. Attention is given to the most used groups, such as cephalosporins and fluoroquinolones, reviewing their basic features and clinical uses, and discusses the pharmacokinetic advantages of the newer members of each group. The older groups (penicillins, aminoglycosides, macrolides and tetracyclines) are also considered with regard to their general features and current uses, and any recent reports on adverse reactions in cats are provided.